Serum albumin level is associated with the recurrence of acute ischemic stroke - 21/08/16
: (Master of Medicine), Yi-Xiong Lei, MD, PhD b , Qiang Wang, MD, PhD a , Yong-Ping Jin, MD a , Rong-Li Fu c , He-Hong Geng, MD, Ma a : (Master of Medicine), Ling-Ling Huang, MD, Ma a : (Master of Medicine), Xiao-Xiao Wang, MD, Ma a : (Master of Medicine), Pei-Xi Wang, MD, PhD a, b, ⁎ Abstract |
Background |
Previous studies have confirmed that low serum albumin levels in acute ischemic stroke patients increased the risk for poor outcome and death, demonstrating the neuroprotective role of albumin. However, there are few studies investigating the relationship between albumin levels and recurrence of stroke. The aim of this study was to evaluate the effect of serum albumin level on the risk of recurrence in patients with acute ischemic stroke.
Methods |
Seven hundred fifty-three consecutive patients with acute first-ever ischemic stroke were recruited in this study. Recurrent outcome was measured 1 year after stroke through home interviews (n = 692).
Results |
Patients with recurrence had significantly lower serum albumin level than those without recurrence (37.07 ± 4.21 vs 38.91 ± 3.25). The multiple logistic regression adjustment for confounding factors showed that the association remained significant for patients in the second albumin quartile, the third quartile, and the fourth quartile compared with patients in the first quartile (adjusted odds ratio [aOR] = 0.543, 95% confidence interval [CI]: 0.307-0.959, P= .036; aOR = 0.449, 95% CI: 0.249-0.812, P= .008; and aOR = 0.290, 95% CI: 0.148-0.570, P < .001).
Conclusion |
Lower serum albumin level increases the risk of recurrence in patients with acute ischemic stroke, suggesting that serum albumin level might be used as an indicator for stroke recurrence.
Le texte complet de cet article est disponible en PDF.Plan
Vol 34 - N° 9
P. 1812-1816 - septembre 2016 Retour au numéro
Article précédent
- A retrospective cross-sectional study of patients treated in US EDs and ambulatory care clinics with sexually transmitted infections from 2001 to 2010
- Chelsea E. Ware, Yasser Ajabnoor, Peter M. Mullins, Maryann Mazer-Amirshahi, Jesse M. Pines, Larissa May
- Amino-terminal pro–B-type natriuretic peptide, inferior vena cava ultrasound, and biolectrical impedance analysis for the diagnosis of acute decompensated CHF
- Paloma Gil Martínez, Daniel Mesado Martínez, Jose Curbelo García, Julen Cadiñanos Loidi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?